Reference : Hic et Nunc. Naevus ou melanome?
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/8907
Hic et Nunc. Naevus ou melanome?
French
[en] Hic et Nunc. Naevus or melanoma?
Pierard, Claudine [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Quatresooz, Pascale mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Arrese Estrada, Jorge [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Rorive, Andrée mailto [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
Fillet, Georges mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
2006
Revue Médicale de Liège
61
1
43-7
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Belgium ; Biomedical Research/trends ; Diagnosis, Differential ; Humans ; Melanoma/diagnosis ; Nevus/diagnosis ; Skin Neoplasms/diagnosis
[en] In Wallonia, the incidence of cutaneous melanoma has steadily increased over the past decades. Hopefully, the early diagnosis made at the premetastatic stage has benefited from great advances both in the clinical and laboratory fields. Thanks to the "Groupement Oncologique Universitaire Wallonie-Liege" (GOUWL) organization, some efforts are currently made in order to better frame and normalize the management of cancer patients. Some medical staffs involved in prospective clinical research bring by their own experience further practical insights for the benefit to the patients. In this field, Belgium is not destituted. We report a brief review of the contribution of the Mosan Study Group of Pigmentary Tumors (GMETP) at the University Hospital of Liege.
http://hdl.handle.net/2268/8907

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
HIC.pdfNo commentaryPublisher postprint428.58 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.